Event Type
Disclosure
Mandatory
Variant
8-K
. Bankruptcy or Receivership. Voluntary Petitions for Bankruptcy On November 15, 2024, Seelos Therapeutics, Inc. (the “ Company ”) filed a voluntary petition fo
. Other Events. On November 18, 2024, the Company was notified by the OTC Markets Group Inc. (the “OTC Markets Group” that its common stock, par value $0.001 pe
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIG